EPO改善肾缺血再灌注损伤中相关信号通路的研究进展

doi:10.3969/j.issn.1006-6233.2025.08.032

摘要
图/表
参考文献
相关文章 (15)

[1] Yang W, Li X, He L, et al. Empagliflozin improves renal ischemia-reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK-OPA1 pathway promotion[J].Cellular & molecular biology letters, 2023, 28(1): 42-61.
[2] Xu S, Chen Y, Zhang L, et al. Neuroprotective effects of arctigenin on cerebral ischemia-reperfusion injury in rats via the EPO/EPOR-JAK2-STAT5 signaling pathway[J].Frontiers in pharmacology, 2025(16):1503971.
[3] Elbaset MA, Mohamed BMSA, Gad SA, et al. Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway[J].Scientific reports,2023,13(1): 14929.
[4] Zou YR, Zhang J, Wang J, et al. Erythropoietin receptor activation protects the kidney from ischemia/reperfusion-induced apoptosis by activating ERK/p53 signal pathway[J].Transplantation Proceedings, 2016, 48(1): 217-221.
[5] Yin W, Rajvanshi PK, Rogers HM, et al. Erythropoietin regulates energy metabolism through EPO-EpoR-RUNX1 axis[J].Nature communications, 2024,15(1): 8114-8131.
[6] Han C, Liu Y, Wu YY, et al. Update on the role and mechanism of erythropoietin receptor in acute kidney injury and repair or fibrosis[J]. Sheng Li Xue Bao, 2023, 75(1): 115-129.
[7] Yasuoka Y, Izumi Y, Fukuyama T, et al. Tubular endogenous erythropoietin protects renal function against ischemic reperfusion injury[J].International journal of molecular sciences,2024, 25(2): 1223.
[8] Kwak J, Kim JH, Jang HN, et al.Erythropoietin ameliorates ischemia/reperfusion-induced acute kidney injury via inflammasome suppression in mice[J]. International Journal of Molecular Sciences, 2020, 21(10): 3453-3464.
[9] Elshiekh M, Kadkhodaee M, Seifi B, et al. Ameliorative effect of recombinant human erythropoietin and ischemic preconditioning on renal ischemia reperfusion injury in rats[J].Nephro-urology monthly, 2015,7(6): 31152.
[10] Lu XH, Zhang J, Xiong Q.Suppressive effect erythropoietin on oxidative stress by targeting AMPK/Nox4/ROS pathway in renal ischemia reperfusion injury[J]. Transplant Immunology, 2022(72): 101537.
[11] Elshiekh M, Kadkhodaee M, Seifi B, et al. Additional effects of erythropoietin pretreatment, ischemic preconditioning, and N-acetylcysteine posttreatment in rat kidney reperfusion injury[J].Turkish journal of medical sciences, 2019,49(4): 1249-1255.
[12] Caetano AM, Vianna Filho PT, Castiglia YM, et al. Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats[J]. Transplantation Proceedings, 2011, 43(10): 3618-3621.
[13] Li W, Cheng F, Songyang YY, et al. CTRP1 Attenuates UUO-induced Renal Fibrosis via AMPK/NOX4 Pathway in Mice[J]. Current Medical Science, 2020, 40(1): 48-54.
[14] Liu L, Liu C, Hou L, et al. Protection against ischemia/reperfusioninduced renal injury by cotreatment with erythropoietin and sodium selenite[J]. Molecular Medicine Reports, 2015, 12(6): 7933-7940.
[15] Imamura R, Moriyama T, Isaka Y, et al. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.[J]. Transplantation, 2007, 83(10): 1371-1379.
[16] El-Maadawy WH, Hassan M, Hafiz E, et al. Co-treatment with esculin and erythropoietin protects against renal ischemia-reperfusion injury via P2X7 receptor inhibition and PI3K/Akt activation.[J]. Scientific Reports, 2022, 12(1): 6239-6251.
[17] Lin Y, Sheng M, Ding Y, et al. Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway[J]. Journal of Natural Medicines, 2018, 72(3): 715-723.
[18] Chen Y, Liu H, Zheng X, et al. SIRT1 ameliorates renal ischemia-reperfusion injury through suppressing endoplasmic reticulum stress-mediated autophagy[J].American journal of translational research,2022, 14(5): 3419-3429.
[19] Zhou S, Qiao YM, Liu YG, et al. Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury[J].Cell & bioscience vol,2020,10(1):130-142.
[20] Yu H, Lin L, Zhang Z, et al. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study[J]. Signal Transduction and Targeted Therapy, 2020, 5(1): 209-232.
[21] Zhang J, Zhao D, Na N, et al. Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation[J]. International Journal of Molecular Medicine,2018,41(1):25-32.
[22] Samson SC, Khan AM, Mendoza MC. ERK signaling for cell migration and invasion[J]. Frontiers in Molecular Biosciences, 2022(9):998475.
[23] Chen X, Wang CC, Song SM, et al. The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling[J].Journal of the Formosan Medical Association,2015,114(5):430-437.